Myocardial infarction (MI) is a major disease posing a significant threat to human health, as it
leads to necrosis of numerous cardiomyocytes (CMs), left ventricle dilation, and cardiac …

Biomedicine and tissue regeneration have made significant advancements recently,
positively affecting the whole healthcare spectrum. This opened the way for them to develop …

Hydrogel patch-based stem cell transplantation and microenvironment-regulating drug
delivery strategy is promising for the treatment of myocardial infarction (MI). However, the …

Myocardial infarction (MI) causes irreversible damage to the heart muscle, seriously
threatening the lives of patients. Injectable hydrogels have attracted extensive attention in …

Developing a potential alternative with safe, minimally invasive, and highly effective
antimicrobial properties is significant for treating bacterial keratitis. In this paper, we present …

Biomedical patches offer significant potential for keratitis treatment. Building on advances in
multifunctionality and biomimicry, an innovative, multifunctional hydrogel patch with high …

Timely reperfusion is the common treatment for myocardial infarction. However, ischemia-
reperfusion (I/R) therapy can lead to oxidative stress and mitochondrial dysfunction that …

The treatment of myocardial infarction (MI) remains a substantial challenge due to excessive
inflammation, massive cell death, and restricted regenerative potential, leading to …

Injectable hydrogels and stem cells have been increasingly applied to treat myocardial
infarction (MI). However, the harsh microenvironment adversely affects the survival of …

The cardiac fibrosis caused by excessive deposition of collagen and the fibro‐inflammatory
cascade reaction severely impedes the cardiac regenerative efficiency after myocardial …